ATE425777T1 - Stents mit wirkstofffreisetzungsbeschichtungen - Google Patents

Stents mit wirkstofffreisetzungsbeschichtungen

Info

Publication number
ATE425777T1
ATE425777T1 AT05808362T AT05808362T ATE425777T1 AT E425777 T1 ATE425777 T1 AT E425777T1 AT 05808362 T AT05808362 T AT 05808362T AT 05808362 T AT05808362 T AT 05808362T AT E425777 T1 ATE425777 T1 AT E425777T1
Authority
AT
Austria
Prior art keywords
therapeutic agent
hydrophilic
hydrophobic
coating
outer layer
Prior art date
Application number
AT05808362T
Other languages
English (en)
Inventor
Jan Weber
Original Assignee
Boston Scient Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scient Ltd filed Critical Boston Scient Ltd
Application granted granted Critical
Publication of ATE425777T1 publication Critical patent/ATE425777T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/624—Nanocapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05808362T 2004-08-26 2005-08-18 Stents mit wirkstofffreisetzungsbeschichtungen ATE425777T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/928,999 US8119153B2 (en) 2004-08-26 2004-08-26 Stents with drug eluting coatings

Publications (1)

Publication Number Publication Date
ATE425777T1 true ATE425777T1 (de) 2009-04-15

Family

ID=35735339

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05808362T ATE425777T1 (de) 2004-08-26 2005-08-18 Stents mit wirkstofffreisetzungsbeschichtungen

Country Status (6)

Country Link
US (1) US8119153B2 (de)
EP (1) EP1791577B1 (de)
AT (1) ATE425777T1 (de)
DE (1) DE602005013405D1 (de)
ES (1) ES2321743T3 (de)
WO (1) WO2006026187A2 (de)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7341598B2 (en) 1999-01-13 2008-03-11 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
WO2004110315A1 (en) * 2003-06-16 2004-12-23 Nanyang Technological University Polymeric stent and method of manufacture
EP1699527A1 (de) 2004-01-02 2006-09-13 Advanced Cardiovascular Systems, Inc. Mit lipoprotein hoher dichte beschichtete medizinprodukte
EP1753369B1 (de) 2004-06-08 2013-05-29 Advanced Stent Technologies, Inc. Stent mit herausragendem astteil für verzweigte gefässe
US20070009564A1 (en) * 2005-06-22 2007-01-11 Mcclain James B Drug/polymer composite materials and methods of making the same
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
EP1909973B1 (de) 2005-07-15 2018-08-22 Micell Technologies, Inc. Polymer-überzüge mit einem arzneipulver mit kontrollierter morphologie
CA2618404A1 (en) * 2005-08-04 2007-02-15 Angiotech International Ag Block copolymer compositions and uses thereof
US7540881B2 (en) 2005-12-22 2009-06-02 Boston Scientific Scimed, Inc. Bifurcation stent pattern
EP1832289A3 (de) * 2006-03-08 2007-12-12 Sahajanand Medical Technologies PVT. ltd Zusammensetzungen und Beschichtungen für implantierbare medizinische Vorrichtungen
US8852625B2 (en) 2006-04-26 2014-10-07 Micell Technologies, Inc. Coatings containing multiple drugs
US9101505B2 (en) * 2006-04-27 2015-08-11 Brs Holdings, Llc Composite stent
US9155646B2 (en) * 2006-04-27 2015-10-13 Brs Holdings, Llc Composite stent with bioremovable ceramic flakes
EP2020956A2 (de) 2006-05-26 2009-02-11 Nanyang Technological University Implantierbarer artikel, verfahren zu seiner herstellung sowie verfahren zur verminderung von thrombogenität
DE102006029247A1 (de) * 2006-06-26 2007-12-27 Biotronik Vi Patent Ag Implantat mit einer Cholesterol- oder Cholesterolester-haltigen Beschichtung
US7794495B2 (en) * 2006-07-17 2010-09-14 Advanced Cardiovascular Systems, Inc. Controlled degradation of stents
US7951191B2 (en) 2006-10-10 2011-05-31 Boston Scientific Scimed, Inc. Bifurcated stent with entire circumferential petal
CA2667228C (en) * 2006-10-23 2015-07-14 Micell Technologies, Inc. Holder for electrically charging a substrate during coating
US20080102123A1 (en) * 2006-10-27 2008-05-01 Schachter Deborah M Self-gelling tunable drug delivery system
US7842082B2 (en) 2006-11-16 2010-11-30 Boston Scientific Scimed, Inc. Bifurcated stent
US20080175887A1 (en) * 2006-11-20 2008-07-24 Lixiao Wang Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8998846B2 (en) 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8425459B2 (en) 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
EP2241342A3 (de) * 2006-11-20 2011-01-12 Lutonix, Inc. Wirkstofffreisetzende Beschichtungen für medizinische Vorrichtungen
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
CN101711137B (zh) 2007-01-08 2014-10-22 米歇尔技术公司 具有可生物降解层的支架
US7758635B2 (en) * 2007-02-13 2010-07-20 Boston Scientific Scimed, Inc. Medical device including cylindrical micelles
EP2146758A4 (de) * 2007-04-17 2012-11-21 Micell Technologies Inc Stents mit biologisch abbaubaren schichten
US9433516B2 (en) 2007-04-17 2016-09-06 Micell Technologies, Inc. Stents having controlled elution
WO2008148013A1 (en) * 2007-05-25 2008-12-04 Micell Technologies, Inc. Polymer films for medical device coating
US8133553B2 (en) 2007-06-18 2012-03-13 Zimmer, Inc. Process for forming a ceramic layer
US8309521B2 (en) 2007-06-19 2012-11-13 Zimmer, Inc. Spacer with a coating thereon for use with an implant device
US8048441B2 (en) * 2007-06-25 2011-11-01 Abbott Cardiovascular Systems, Inc. Nanobead releasing medical devices
US20090069878A1 (en) * 2007-08-27 2009-03-12 Boston Scientific Scimed, Inc. Bifurcation post-dilatation balloon and methods
US8333795B2 (en) * 2007-08-27 2012-12-18 Boston Scientific Scimed, Inc. Bulging balloon for bifurcation catheter assembly and methods
US7959669B2 (en) 2007-09-12 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent with open ended side branch support
US20090081272A1 (en) * 2007-09-24 2009-03-26 John Clarke Medical devices having a metal particulate composition for controlled diffusion
US20110230973A1 (en) * 2007-10-10 2011-09-22 Zimmer, Inc. Method for bonding a tantalum structure to a cobalt-alloy substrate
US8608049B2 (en) * 2007-10-10 2013-12-17 Zimmer, Inc. Method for bonding a tantalum structure to a cobalt-alloy substrate
US20100298928A1 (en) * 2007-10-19 2010-11-25 Micell Technologies, Inc. Drug Coated Stents
US7833266B2 (en) 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
EP2219625B1 (de) * 2007-12-13 2012-08-01 Kyushu University, National University Corporation Wirkstoffhaltige Nanopartikel enthaltend Pioglitazon
US8277501B2 (en) 2007-12-21 2012-10-02 Boston Scientific Scimed, Inc. Bi-stable bifurcated stent petal geometry
US20090187256A1 (en) * 2008-01-21 2009-07-23 Zimmer, Inc. Method for forming an integral porous region in a cast implant
US20090198286A1 (en) * 2008-02-05 2009-08-06 Zimmer, Inc. Bone fracture fixation system
CA2721832C (en) 2008-04-17 2018-08-07 Micell Technologies, Inc. Stents having bioabsorbable layers
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US8206636B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US10898620B2 (en) 2008-06-20 2021-01-26 Razmodics Llc Composite stent having multi-axial flexibility and method of manufacture thereof
US8206635B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
JP2011528275A (ja) * 2008-07-17 2011-11-17 ミセル テクノロジーズ，インク． 薬物送達医療デバイス
WO2010019645A2 (en) * 2008-08-14 2010-02-18 Boston Scientific Scimed, Inc. Medical devices having electrodeposited conductive polymer coatings
WO2010024898A2 (en) 2008-08-29 2010-03-04 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
US20100104652A1 (en) * 2008-10-27 2010-04-29 University Of Arkansas Use of advanced nanomaterials for increasing sepecific cell functions
US8834913B2 (en) * 2008-12-26 2014-09-16 Battelle Memorial Institute Medical implants and methods of making medical implants
EP2411083A4 (de) * 2009-03-23 2013-11-13 Micell Technologies Inc Medizinische wirkstofffreisetzungsvorrichtung
CA2756388C (en) * 2009-03-23 2015-10-27 Micell Technologies, Inc. Biodegradable polymers with low acidic impurity
CN102481195B (zh) 2009-04-01 2015-03-25 米歇尔技术公司 涂覆支架
SG175373A1 (en) 2009-04-28 2011-11-28 Surmodics Inc Devices and methods for delivery of bioactive agents
NZ597307A (en) * 2009-06-02 2014-04-30 Concept Medical Inc Rejuvenating coronary artery by improving blood flow with the help of insertion of nano-balls (encapsulated nanoparticles) containing therapeutic agents by non implantable device for tissues and thereby providing in tissue release to address the required cell cycle
RU2012111217A (ru) * 2009-08-26 2013-10-10 Оцука Медикал Дивайсез Ко., Лтд. Медицинское устройство для размещения в просвете и способ его изготовления
EP2531140B1 (de) * 2010-02-02 2017-11-01 Micell Technologies, Inc. Stent und stenteinsatzsystem mit verbesserter einsetzbarkeit
US8795762B2 (en) 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
WO2011133655A1 (en) 2010-04-22 2011-10-27 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
EP2593039B1 (de) 2010-07-16 2022-11-30 Micell Technologies, Inc. Medizinische wirkstofffreisetzungsvorrichtung
US9757497B2 (en) 2011-05-20 2017-09-12 Surmodics, Inc. Delivery of coated hydrophobic active agent particles
US9861727B2 (en) 2011-05-20 2018-01-09 Surmodics, Inc. Delivery of hydrophobic active agent particles
US10213529B2 (en) 2011-05-20 2019-02-26 Surmodics, Inc. Delivery of coated hydrophobic active agent particles
WO2012166819A1 (en) 2011-05-31 2012-12-06 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
CA2841360A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
WO2013059509A1 (en) * 2011-10-18 2013-04-25 Micell Technologies, Inc. Drug delivery medical device
US9220759B2 (en) 2012-02-23 2015-12-29 Abbott Cardiovascular Systems Inc. Treatment of diabetic patients with a drug eluting stent and adjunctive therapy
US9220584B2 (en) 2012-03-30 2015-12-29 Abbott Cardiovascular Systems Inc. Treatment of diabetic patients with a stent and locally administered adjunctive therapy
US20130259921A1 (en) * 2012-03-30 2013-10-03 Abbott Cardiovascular Systems Inc. Treatment Of Diabetic Patients With A Stent And An Adjunctive Drug Formulation
JP6438406B2 (ja) 2012-11-05 2018-12-12 サーモディクス，インコーポレイテッド 疎水性生理活性物質を送達するための組成物および方法
US11246963B2 (en) 2012-11-05 2022-02-15 Surmodics, Inc. Compositions and methods for delivery of hydrophobic active agents
WO2014165264A1 (en) 2013-03-12 2014-10-09 Micell Technologies, Inc. Bioabsorbable biomedical implants
KR102079613B1 (ko) 2013-05-15 2020-02-20 미셀 테크놀로지즈, 인코포레이티드 생흡수성 생체의학적 임플란트
US11406742B2 (en) 2014-07-18 2022-08-09 M.A. Med Alliance SA Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs
US9492594B2 (en) * 2014-07-18 2016-11-15 M.A. Med Alliance SA Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs
CA2974962C (en) * 2015-01-29 2024-01-09 Surmodics, Inc. Delivery of hydrophobic active agent particles
US10898446B2 (en) 2016-12-20 2021-01-26 Surmodics, Inc. Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
WO2018181179A1 (ja) * 2017-03-30 2018-10-04 テルモ株式会社 親水性部材と疎水性部材とを積層させた医療機器
EP3470056B1 (de) * 2017-10-16 2022-04-27 Medtronic Vascular Inc. Therapeutische nanopartikel zur behandlung von gefässerkrankungen
US20220133647A1 (en) * 2019-03-01 2022-05-05 Avadel Legacy Pharmaceuticals, Llc Liquid guaifenesin compositions with stable extended release profiles

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US20030203976A1 (en) 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
NZ533467A (en) 1993-07-19 2006-02-24 Angiotech Pharm Inc Anti-angiogenic compositions and methods of use
WO1995003795A1 (en) 1993-07-29 1995-02-09 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
US5500161A (en) 1993-09-21 1996-03-19 Massachusetts Institute Of Technology And Virus Research Institute Method for making hydrophobic polymeric microparticles
EP0804249A2 (de) 1994-03-15 1997-11-05 Brown University Research Foundation Polymeres system zur freisetzung von genen
US6007845A (en) 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US6294202B1 (en) * 1994-10-06 2001-09-25 Genzyme Corporation Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers
US6179817B1 (en) 1995-02-22 2001-01-30 Boston Scientific Corporation Hybrid coating for medical devices
NZ505584A (en) 1996-05-24 2002-04-26 Univ British Columbia Delivery of a therapeutic agent to the smooth muscle cells of a body passageway via an adventia
US6013855A (en) * 1996-08-06 2000-01-11 United States Surgical Grafting of biocompatible hydrophilic polymers onto inorganic and metal surfaces
US6174329B1 (en) 1996-08-22 2001-01-16 Advanced Cardiovascular Systems, Inc. Protective coating for a stent with intermediate radiopaque coating
US5993972A (en) 1996-08-26 1999-11-30 Tyndale Plains-Hunter, Ltd. Hydrophilic and hydrophobic polyether polyurethanes and uses therefor
US6056973A (en) 1996-10-11 2000-05-02 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method of preparation
US6099561A (en) 1996-10-21 2000-08-08 Inflow Dynamics, Inc. Vascular and endoluminal stents with improved coatings
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6443949B2 (en) 1997-03-13 2002-09-03 Biocardia, Inc. Method of drug delivery to interstitial regions of the myocardium
UA54505C2 (uk) 1997-04-03 2003-03-17 Гілфорд Фармасьютікалз Інк. Полімери, що біологічно розкладаються, зшиті фосфатами, композиції, вироби і способи для їх виготовлення і використання
DE19882362T1 (de) * 1997-04-30 2000-05-18 Point Biomedical Corp Mikropartikel, geeignet als Ultraschallkontrastmittel und zum Transport von Arzneimitteln in den Blutstrom
WO1998056312A1 (en) * 1997-06-13 1998-12-17 Scimed Life Systems, Inc. Stents having multiple layers of biodegradable polymeric composition
US5899935A (en) 1997-08-04 1999-05-04 Schneider (Usa) Inc. Balloon expandable braided stent with restraint
US5854382A (en) 1997-08-18 1998-12-29 Meadox Medicals, Inc. Bioresorbable compositions for implantable prostheses
EP1647270B1 (de) 1998-03-19 2009-06-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zum Aufbringen mehrerer Schichten von Beschichtungssubstanzen auf Templatpartikel
US20030040790A1 (en) * 1998-04-15 2003-02-27 Furst Joseph G. Stent coating
JP4650976B2 (ja) 1998-07-15 2011-03-16 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ 生物学的テンプレート上の高分子電解質
WO2000013666A1 (en) 1998-09-05 2000-03-16 Seung Jin Lee Biodegradable particulate polymeric preparation and process for producing thereof
IN191203B (de) 1999-02-17 2003-10-04 Amarnath Prof Maitra
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6368658B1 (en) 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
ES2184716T3 (es) 1999-06-10 2003-04-16 Max Planck Gesellschaft Encapsulacion de cristales por medio de recubrimientos multicapa.
US6258121B1 (en) 1999-07-02 2001-07-10 Scimed Life Systems, Inc. Stent coating
US20030144570A1 (en) 1999-11-12 2003-07-31 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors
EP1255576B1 (de) 1999-12-09 2003-08-20 Biosyntech Canada Inc. Mineral-polymer hybrid-zusammensetzung
DE10001172A1 (de) 2000-01-13 2001-07-26 Max Planck Gesellschaft Templatieren von Feststoffpartikeln mit Polymermultischichten
US20040013738A1 (en) 2000-08-02 2004-01-22 Andreas Voigt Encapsulation of liquid template particles
CA2420523C (en) 2000-08-28 2010-05-25 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Controlled and sustained release properties of polyelectrolyte multilayer capsules
US20020111590A1 (en) * 2000-09-29 2002-08-15 Davila Luis A. Medical devices, drug coatings and methods for maintaining the drug coatings thereon
GB0100761D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
GB0100760D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US6730324B2 (en) 2001-04-20 2004-05-04 The University Of British Columbia Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
US20030099674A1 (en) 2001-08-11 2003-05-29 Chen Andrew X. Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
EP1434571B1 (de) 2001-10-05 2005-05-11 SurModics, Inc. Beschichtungen mit immobilisierten partikeln sowie verwendungen derselben
US20030134811A1 (en) 2001-10-09 2003-07-17 John Jackson Methods and compositions comprising hydroxyapatite useful for the administration of therapeutic agents
EP1310242A1 (de) 2001-11-13 2003-05-14 SORIN BIOMEDICA CARDIO S.p.A. Träger und Kit für endoluminale Wirkstoffabgabe
US7939094B2 (en) 2002-06-19 2011-05-10 Boston Scientific Scimed, Inc. Multiphase polymeric drug release region
US20050181015A1 (en) 2004-02-12 2005-08-18 Sheng-Ping (Samuel) Zhong Layered silicate nanoparticles for controlled delivery of therapeutic agents from medical articles

Also Published As

Publication number Publication date
EP1791577A2 (de) 2007-06-06
ES2321743T3 (es) 2009-06-10
DE602005013405D1 (de) 2009-04-30
WO2006026187A2 (en) 2006-03-09
WO2006026187A3 (en) 2006-05-26
US20060045901A1 (en) 2006-03-02
US8119153B2 (en) 2012-02-21
EP1791577B1 (de) 2009-03-18

Similar Documents

Publication Publication Date Title
ATE425777T1 (de) Stents mit wirkstofffreisetzungsbeschichtungen
WO2007084361A3 (en) Coated medical devices and methods of making the same
WO2006014969A3 (en) Medical device having a coating layer with structural elements therein and method of making the same
WO2007126768A3 (en) Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
WO2004000379A8 (en) Stent coatings with sustained drug release rate
DE602005016044D1 (de) Deckbeschichtung enhaltend Heparin für kontrollierte Wirkstoffabgabe
WO2004030678A3 (en) Polymer compositions containing bioactive agents and methods for their use
EP2500044A3 (de) Beschichtungen für medizinische Geräte zur schnellen Wirkstofffreisetzung mit einem therapeutischen Mittel und einem Kontrastmittel
WO2006052575A3 (en) Medical device for delivering therapeutic agents over different time periods
WO2008002586A3 (en) Coatings for medical devices comprising a therapeutic agent and a metallic material
WO2009099935A3 (en) Drug-coated medical devices for differential drug release
ATE508708T1 (de) Medizinprodukte mit wirkstofffreisetzender beschichtung
WO2005097228A3 (en) Coating compositions for bioactive agents
WO2009014696A3 (en) Medical devices with coatings for delivery of a therapeutic agent
WO2003024455A8 (en) Stent coated with a sustained-release drug delivery and method for use thereof
ATE290895T1 (de) Stents mit arzneimittelhaltigem amphiphilem polymerüberzug
ATE423578T1 (de) Medizinprodukt mit einem biologischen wirkstoff
WO2009059166A3 (en) Endoprosthesis with porous reservoir and non-polymer diffusion layer
WO2008144130A3 (en) Implantable medical devices with a topcoat layer of phosphoryl choline acrylate polymer for reduced thrombosis, and improved mechanical properties
WO2008091925A3 (en) Treatment of aortic dissection or aneurysm
WO2007146001A3 (en) Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug
AU2003217329A1 (en) Coated vascular prosthesis and methods of manufacture and use.
WO2006020742A3 (en) Medical devices having nanoporous layers and methods for making the same
DE602005018178D1 (de) Phospholipid und verunreinigungsbeständige beschichtungszusammensetzungen
WO2010025078A3 (en) Endoprostheses with porous regions and non-polymeric coating

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties